U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06870058) titled 'A Study of NH280105 in Healthy Adult Participants' on March 05.
Brief Summary: This is a Phase 1, randomized, double-blinded, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NH280105 in healthy volunteers. In addition, this study will evaluate the effects of food on NH280105 under a two-period study setting.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DRUG: NH280105- SAD
Dose formulation: Capsule Route of administration: oral
DRUG: NH280105- MAD...